A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome

BJU International

Volumn 100, Issue 4, 2007, Pages 840-845

  Robinson, Dudley ^a   Cardozo, Linda ^a   Terpstra, Gerben ^b   Bolodeoku, John ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b Astellas Pharma Global Development   (Netherlands)

Author keywords

Female; Overactive bladder; Tamsulosin

Indexed keywords

PLACEBO; TAMSULOSIN; TOLTERODINE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NOCTURIA; OVERACTIVE BLADDER; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME; URINARY URGENCY; URINE INCONTINENCE; XEROSTOMIA;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; BENZHYDRYL COMPOUNDS; CRESOLS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; QUALITY OF LIFE; SINGLE-BLIND METHOD; SULFONAMIDES; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 34548422032     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07162.x     Document Type: Article

References (23)

1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function. Report from the standardisation committee of the International Continence Society. Neurourol Urodynam 2002 21 : 167 78
2. Stewart WF, Corey R, Herzog AR et al. Prevalence of overactive bladder in women: results from the NOBLE program. Int Urogynaecol J 2001 12 : S66
3. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001 87 : 760 6
4. Andersson K-E. The overactive bladder. Pharmacologic basis of drug treatment. Urology 1997 50 (Suppl. 74 84
5. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 1997 104 : 988 93
6. Shaya FT, Blume S, Gu A, Zyczynski T, Jumadilova Z. Persistence with overactive bladder pharmacotherapy in a Medicaid population. Am J Manag Care 2005 11 : S121 9
7. Haab F, Castro-Diaz D. Persistence with antimuscarinic therapy in patients with overactive bladder. Int J Clin Pract 2005 59 : 931 7
8. 1 Adrenergic receptor subtypes in human detrusor. J Urol 1998 160 : 937 43
9. Schwinn DA. Novel role for alpha 1-adrenergic receptor sub-types in lower urinary tract symptoms. BJU Int 2000 86 (Suppl. 2 11 20
10. 1-adrenoceptor selectivity? Br J Urol 1995 76 (Suppl. 1 47 55
11. Blaivis JG. Issues of uroselectivity in male and female LUTS. BJU Int 2000 86 (Suppl. 2 1 10
12. 1- adrenoceptor antagonists. BJU Int 2000 85 (Suppl. 2 1 5
13. Andersson K-E. Alpha-blockers and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists. World J Urol 2002 19 : 390
14. Arnold BP. Tamsulosin in men with confirmed bladder outlet obstruction. a clinical and urodynamic analysis from a single centre in New Zealand BJU Int 2001 87 : 24
15. Webster JR. Combined video/pressure/flow cystometrography in female patients with voiding disturbances. Urology 1975 5 : 209 13
16. Cardozo LD, Stanton SL, Williams JE. Detrusor instability following surgery for genuine stress incontinence. Br J Urol 1979 51 : 204 7
17. Srinivasan V, Blackford HN. Genuine stress incontinence induced by prazosin. Br J Urol 1993 72 : 510
18. Rachagan SP, Matthews A. Urinary incontinence caused by prazosin. Singapore Med J 1992 33 : 308 9
19. Menefee SA, Chesson R, Wall LL. Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting enzyme inhibitors. Obstet Gynaecol 1998 91 : 853 4
20. Wall LL, Addison WA. Prazosin-induced stress incontinence. Obstet Gynaecol 1990 75 : 558 60
21. Dwyer PL, Teele JS. Prazosin: a neglected cause of genuine stress incontinence. Obstet Gynaecol 1992 79 : 117 21
22. Van Kerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A Tolterodine Study Group. Tolterodine once-daily: superior efficacy and tolerability in the treatment of overactive bladder. Urology 2001 57 : 414 21
23. Swift S, Garely A, Dimpfl T, Payne C Tolterodine Study Group. A new once daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder. Int J Pelvic Floor Dysfunct 2003 14 : 50 4